Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-02-26 @ 7:49 PM
Study NCT ID:
NCT02730208
Status:
COMPLETED
Last Update Posted:
2019-10-23
First Post:
2016-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-31
First Submit QC Date:
None
Study First Post Date:
2016-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-30
Results First Submit QC Date:
None
Results First Post Date:
2019-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-22
Last Update Post Date:
2019-10-23
Last Update Post Date Type:
ACTUAL